Did you know?

ChinaBio® Group is a consulting and advisory firm helping life science companies and investors achieve success in China. ChinaBio works with U.S., European and APAC companies and investors seeking partnerships, acquisitions, novel technologies and funding in China.  

Learn more >>

Free Newsletter

Have the latest stories on China's life science industry delivered to your inbox daily or weekly - free!

  Email address:
   

Top Stories

Recent articles that are of ongoing interest...

Shanghai Green Valley Surprises with China Approval for Alzheimer's Treatment

Amgen to Make $2.7 Billion Investment in BeiGene; BeiGene to Develop 23 Amgen Candidates in China

Shanghai Pharma Forms $250 Million China Antibody JV with Russia's Biocad

Hansoh Forms $1.5 Billion Partnership with Atomwise, an AI Drug Discovery Company

PAG Pays $540 Million for Majority Stake in Hisun BioRay, a Biologics Company

ChinaBio® News

Greg Scott BIO-Europe Interview
Greg Scott Interviewed at BIO-Europe Spring

How to bring your China assets to China in 8 minutes


Greg Scott Mendelspod Interview
"Mr. Bio in China."
Mendelspod Interview

Multinational pharma held to a higher standard in China